Prediction model for 30-day morbidity after gynecological malignancy surgery.

The potential risk of postoperative morbidity is important for gynecologic cancer patients because it leads to delays in adjunctive therapy and additional costs. We aimed to develop a preoperative nomogram to predict 30-day morbidity after gynecological cancer surgery.Between 2005 and 2015, 533 cons...

Full description

Bibliographic Details
Main Authors: Seung-Hyuk Shim, Sun Joo Lee, Meari Dong, Jung Hwa Suh, Seo Yeon Kim, Ji Hye Lee, Soo-Nyung Kim, Soon-Beom Kang, Jayoun Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5453555?pdf=render
_version_ 1818480382930059264
author Seung-Hyuk Shim
Sun Joo Lee
Meari Dong
Jung Hwa Suh
Seo Yeon Kim
Ji Hye Lee
Soo-Nyung Kim
Soon-Beom Kang
Jayoun Kim
author_facet Seung-Hyuk Shim
Sun Joo Lee
Meari Dong
Jung Hwa Suh
Seo Yeon Kim
Ji Hye Lee
Soo-Nyung Kim
Soon-Beom Kang
Jayoun Kim
author_sort Seung-Hyuk Shim
collection DOAJ
description The potential risk of postoperative morbidity is important for gynecologic cancer patients because it leads to delays in adjunctive therapy and additional costs. We aimed to develop a preoperative nomogram to predict 30-day morbidity after gynecological cancer surgery.Between 2005 and 2015, 533 consecutive patients with elective gynecological cancer surgery in our center were reviewed. Of those patients, 373 and 160 patients were assigned to the model development or validation cohort, respectively. To investigate independent predictors of 30-day morbidity, a multivariate Cox regression model with backward stepwise elimination was utilized. A nomogram based on this Cox model was developed and externally validated. Its performance was assessed using the concordance index and a calibration curve.Ninety-seven (18.2%) patients had at least one postoperative complication within 30 days after surgery. After bootstrap resampling, the final model indicated age, operating time, and serum albumin level as statistically significant predictors of postoperative morbidity. The bootstrap-corrected concordance index of the nomogram incorporating these three predictors was 0.656 (95% CI, 0.608-0.723). In the validation cohort, the nomogram showed fair discrimination [concordance index: 0.674 (95% CI = 0.619-0.732] and good calibration (P = 0.614; Hosmer-Lemeshow test).The 30-day morbidity after gynecologic cancer surgery could be predicted according to age, operation time, and serum albumin level. After further validation using an independent dataset, the constructed nomogram could be valuable for predicting operative risk in individual patients.
first_indexed 2024-12-10T11:22:46Z
format Article
id doaj.art-f92885881301403cb2328bb883191d94
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T11:22:46Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f92885881301403cb2328bb883191d942022-12-22T01:50:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017861010.1371/journal.pone.0178610Prediction model for 30-day morbidity after gynecological malignancy surgery.Seung-Hyuk ShimSun Joo LeeMeari DongJung Hwa SuhSeo Yeon KimJi Hye LeeSoo-Nyung KimSoon-Beom KangJayoun KimThe potential risk of postoperative morbidity is important for gynecologic cancer patients because it leads to delays in adjunctive therapy and additional costs. We aimed to develop a preoperative nomogram to predict 30-day morbidity after gynecological cancer surgery.Between 2005 and 2015, 533 consecutive patients with elective gynecological cancer surgery in our center were reviewed. Of those patients, 373 and 160 patients were assigned to the model development or validation cohort, respectively. To investigate independent predictors of 30-day morbidity, a multivariate Cox regression model with backward stepwise elimination was utilized. A nomogram based on this Cox model was developed and externally validated. Its performance was assessed using the concordance index and a calibration curve.Ninety-seven (18.2%) patients had at least one postoperative complication within 30 days after surgery. After bootstrap resampling, the final model indicated age, operating time, and serum albumin level as statistically significant predictors of postoperative morbidity. The bootstrap-corrected concordance index of the nomogram incorporating these three predictors was 0.656 (95% CI, 0.608-0.723). In the validation cohort, the nomogram showed fair discrimination [concordance index: 0.674 (95% CI = 0.619-0.732] and good calibration (P = 0.614; Hosmer-Lemeshow test).The 30-day morbidity after gynecologic cancer surgery could be predicted according to age, operation time, and serum albumin level. After further validation using an independent dataset, the constructed nomogram could be valuable for predicting operative risk in individual patients.http://europepmc.org/articles/PMC5453555?pdf=render
spellingShingle Seung-Hyuk Shim
Sun Joo Lee
Meari Dong
Jung Hwa Suh
Seo Yeon Kim
Ji Hye Lee
Soo-Nyung Kim
Soon-Beom Kang
Jayoun Kim
Prediction model for 30-day morbidity after gynecological malignancy surgery.
PLoS ONE
title Prediction model for 30-day morbidity after gynecological malignancy surgery.
title_full Prediction model for 30-day morbidity after gynecological malignancy surgery.
title_fullStr Prediction model for 30-day morbidity after gynecological malignancy surgery.
title_full_unstemmed Prediction model for 30-day morbidity after gynecological malignancy surgery.
title_short Prediction model for 30-day morbidity after gynecological malignancy surgery.
title_sort prediction model for 30 day morbidity after gynecological malignancy surgery
url http://europepmc.org/articles/PMC5453555?pdf=render
work_keys_str_mv AT seunghyukshim predictionmodelfor30daymorbidityaftergynecologicalmalignancysurgery
AT sunjoolee predictionmodelfor30daymorbidityaftergynecologicalmalignancysurgery
AT mearidong predictionmodelfor30daymorbidityaftergynecologicalmalignancysurgery
AT junghwasuh predictionmodelfor30daymorbidityaftergynecologicalmalignancysurgery
AT seoyeonkim predictionmodelfor30daymorbidityaftergynecologicalmalignancysurgery
AT jihyelee predictionmodelfor30daymorbidityaftergynecologicalmalignancysurgery
AT soonyungkim predictionmodelfor30daymorbidityaftergynecologicalmalignancysurgery
AT soonbeomkang predictionmodelfor30daymorbidityaftergynecologicalmalignancysurgery
AT jayounkim predictionmodelfor30daymorbidityaftergynecologicalmalignancysurgery